| Job Title | Company |
| Partner | 4BIO Capital Partners |
| Partner | 4BIO Capital Partners |
| Partner | Abingworth |
| CEO | Abzena |
| Investor Relations Associate | Abzena |
| CFO | Abzena |
| Senior VP Corporate Development | Abzena |
| Head of Technology Affairs | Advantage Austria London |
| General Partner | Advent Life Sciences |
| General Partner | Advent Life Sciences |
| Managing Director | Aetas Global |
| Director | Aetas Global |
| Managing Director | Akesios Associates |
| Partner | Albion Ventures |
| Investment Manager | Alderley Park Ventures |
| Chairman | Alderley Park Ventures |
| CEO & Founder | Allergy Therapeutics |
| CFO | Allergy Therapeutics |
| CFO | Alliance Pharma |
| Head of External Innovation and Licensing | Almirall |
| Business Development Manager | Alviol |
| CEO | Alviol |
| Chief Executive | Amadeus Capital Partners |
| Investment Manager, Early Stage Funds | Amadeus Capital Partners |
| CEO | Angel Capital Group |
| Director | Anglezarke Life Sciences |
| Director | Antikor Biopharma |
| Chief Science Officer | Antikor Biopharma |
| CEO | Apitope |
| Founder | Arrowfield Capital |
| Investment Director | Arthurian Life Sciences |
| CEO | Astex Pharmaceuticals |
| Vice President, Business Development Operations | AstraZeneca |
| Vice President, Head of Transactions (UK), Business Development | AstraZeneca |
| Executive Vice President Innovative Medicines and Early Research | AstraZeneca |
| Transaction Director, Business Development Operations | AstraZeneca |
| BD Director | Atelix |
| CEO | Attomaker |
| CEO | Autotelic |
| CSO | Avexxin |
| Head of Business Development | Avexxin |
| Relationship Director, Healthcare | Barclays Corporate |
| Relationship Director, Healthcare | Barclays Corporate |
| CEO | Belsize Asset Management |
| Financial Analyst | Bergen Asset Management |
| CEO | BioMoti |
| Editor, EMEA | BioPharm Insight |
| Business Development Manager | BioPharm Insight |
| Business Development Manager | BioPharm Insight |
| Media Manager | Biotech and Money |
| Chief Marketing Officer | Biotech and Money |
| Co-CEO | Biotech and Money |
| Co-CEO | Biotech and Money |
| Head of European Research, Pharmaceuticals Analyst | Bloomberg |
| European Health and Science Reporter | Bloomberg News |
| CEO | Blue Earth Diagnostics |
| SVP & Head of Business Development | BTG |
| Executive Chairman | C4X Discovery |
| CSO | C4X Discovery |
| Head of Life Sciences | Cambridge Enterprise |
| Director | Cambridge Innovation Capital |
| Investment Director | Cambridge Innovation Capital |
| Chief Executive Officer | Cambridge Medical Robotics |
| CEO | Cancer Research Technology |
| Executive Director of Business Managemet | Cancer Research Technology |
| CEO | Catapult Ventures |
| Chairman | Cell Therapy Catapult |
| CBO | Cell Therapy Catapult |
| CEO | Cell Therapy Catapult |
| CEO | CellCentric |
| Director of Research, Head of Healthcare Research | Chardan Capital Markets |
| Chief Executive Officer | Chronos Therapeutics |
| VP Corporate Development | Chronos Therapeutics |
| CEO | Clinigen |
| Senior Associate | CMS Cameron McKenna |
| Corporate Partner and Head of Equity Capital Markets | CMS Cameron McKenna |
| Partner | CMS Cameron McKenna |
| Director of Licensing | CN Bio Innovations |
| CEO | CN Bio Innovations |
| CMO | Combebelle Life |
| Managing Partner | Consilium Strategic |
| Partner and Co-Founder | Consilium Strategic |
| Partner and Co-Founder | Consilium Strategic |
| Managing Partner | Coulter Partners |
| Senior Consultant | Coulter Partners |
| Director | Coulter Partners |
| Partner, Corporate Practice, Europe | Covington & Burling |
| Partner and Head, Corporate Practice, Europe | Covington & Burling |
| Partner | Covington & Burling |
| Partner | Covington & Burling |
| Partner, Corporate Practice, Europe | Covington & Burling |
| Partner | Covington & Burling |
| Partner | Covington & Burling |
| CEO | Crescendo Biologics |
| Founder & CEO | Curileum Discovery |
| Co-Founder | Customem |
| Co-Founder | Customem |
| Reporter | Dealreporter |
| CEO | Diurnal Group |
| Chairman | Domainex / Canbex Therapeutics |
| CEO Designate | Dynamic Consent |
| Founder and CEO | Dynasty Biotechnology and the Dynasty Fund |
| CEO | Edinburgh Molecular Imaging |
| Director Business Development Europe & Canada | Eli Lilly and Co. |
| Sen Director, Search & Evaluation - Neuroscience | Eli Lilly and Co. |
| Director of External Innovation for Global External Research & Development | Eli Lilly and Co. |
| Associate, External Innovation - Neuroscience | Eli Lilly and Co. |
| Editor | EP Vantage |
| Managing Partner | Epidarex Capital |
| Venture Partner | Epidarex Capital |
| CEO Designate | Episynesis |
| CFO | Ergomed |
| CEO | Ergomed |
| CEO Designate | EstryX Pharma |
| Executive Editor | Evernow Publishing |
| Editor | Evernow Publishing |
| President & COO | Evofem |
| Head of Life Sciences Transaction Advisory, Europe, Middle East, Africa and India, | EY |
| Director, Life Sciences M&A | EY |
| Head of Life Sciences | EY |
| Head of UK Life Sciences M&A | EY |
| CEO | F-star Biotechnology |
| CEO | Faron Pharmaceuticals |
| Deputy Fund Manager | Finance Wales |
| Managing Partner | Forbion Capital |
| Healthcare / Pharma Journalist | Freelancer |
| Vice President | FreeMind Group |
| President and CEO | FRESCA Medical |
| Chief Operating Officer | Genalice |
| Chief Executive Officer / Chief Technology Officer | Genalice |
| Managing Director | Genesis Genetics |
| Executive Partner and Founder | GHO Capital Partners |
| Partner | Gill Jennings & Every |
| Partner | Gill Jennings & Every |
| Director, Transactions | GSK |
| Head of WWBD | GSK |
| Director, Academic Liaison | GSK |
| Chief Immunology Officer & SVP R&D Pipeline | GSK |
| Managing Director | Hadean Ventures |
| Venture Partner | Hadean Ventures |
| Investor | Harbert Management Corporation |
| Managing Director | HealthCare Royalty Partners |
| CEO | Helomics Corporation |
| CEO | Horizon Discovery |
| Corporate Development Manager | Horizon Discovery |
| CFO | Horizon Discovery |
| Innovations Advisor | HSC Innovations |
| Managing Director International Healthcare | Hume Brophy |
| Director | Hume Brophy |
| CFBO | hVIVO |
| Managing Director Europe | Ignite Capital Partners |
| Finance and Commercial Director | Imanova |
| Chief Business Officer | Immunocore |
| Director of Healthcare Investment | Imperial Innovations |
| CEO | Imperial Innovations |
| Director of Communications | Imperial Innovations |
| Managing Director, Tech Transfer | Imperial Innovations |
| Chief Investment Officer | Imperial Innovations |
| Senior Executive | Imperial Innovations |
| Internist & Nephrologist | Independent |
| Venture Partner | Index Ventures |
| Associate | Index Ventures |
| CEO | Inflamalps |
| Access to Finance Manager | Innovate UK |
| Head of Healthcare | Innovate UK |
| Partner | Instinctif Partners |
| Director of Enterprise | Institute of Cancer Research |
| Principal | Inventages |
| Head, Biotech | IP Group |
| International Media Director | IPI - International Pharmaceutical Industry |
| SVP - Corporate Business Development | Ipsen |
| IP & Business Strategy | ISA Pharmaceuticals |
| Chief Business Officer | ISA Pharmaceuticals |
| Head of Technology Transfer | Isis Innovation |
| CFO | IXICO |
| Patent Attorney | J A Kemp |
| Co-Founder | JAG Shaw Baker |
| Special Counsel | JAG Shaw Baker |
| Partner | James Cowper Kreston |
| Partner | James Cowper Kreston |
| Executive Director Healthcare | JP Morgan |
| CEO | Karus Therapeutics |
| Commercial Portfolio Manager | King’s College London |
| Commercial Portfolio Manager | King’s College London |
| CEO | Kirkstall |
| Founder | Klein-Edmonds Associates |
| Managing Partner | Kreos Capital |
| Analyst, Europe Offering | L1 Capital Pty |
| Biotech analyst, Europe Offering | L1 Capital Pty |
| Deputy CEO, Europe Offering | L1 Capital Pty |
| UK Alpha Fund Manager | Legal & General Investment Management |
| Analyst | Levrett |
| CEO | Levrett |
| Principal | LHVC |
| COO | Life Sciences Hub Wales |
| Head of BD and Finance | Lipotype |
| Consultant, Primary Markets | London Stock Exchange |
| Managing Partner | Longbow Capital |
| Managing Partner | Longbow Capital |
| EIR | Loxbridge |
| Partner | Loxbridge |
| CEO | Mann Bioinvest |
| Serial Entrepreneur and Founder | Mann Bioinvest |
| CEO | Maria Magle Holding |
| CEO | MedCity |
| CEO | Medherant |
| CEO | Medicortex Finland |
| Head of LIfe Sciences | Mercia Fund Management |
| Executive Vice President, Head of Global Business Development & Strategy | Merck KGaA |
| Director | Metis Life Science |
| CEO | MiNA Therapeutics |
| CEO | MISSION Therapeutics |
| CEO | Mitotech |
| COO | Mitotech |
| Director | Mobius Technology Ventures |
| General Counsel | MRC Technology |
| Finance Director | MRC Technology |
| Partner | MS Ventures |
| Partner / Inventor | MSI Ltd. |
| Partner | MVM Life Science Partners |
| Partner | MVM Life Science Partners |
| CEO | Nanobiotix |
| CFO | Nanobiotix |
| Managing Director, EMEA | Nasdaq |
| EVP, EMEA | Nasdaq |
| BD Director, Europe | Nasdaq |
| Managing Director | Nasdaq |
| Investment Director | NBGI Private Equity Limited |
| Chief Investment Officer | NetScientific |
| CEO | NetScientific |
| Analyst, Investments & Corporate Development | NetScientific |
| CFO | NetScientific |
| CEO | NightstaRx |
| Managing Partner | Novasecta |
| Director, Healthcare Equity Research | Numis Securities Limited |
| Director, Equity Research | Numis Securities Limited |
| CEO | O2h Ventures Limited |
| VC | Omega Funds |
| Chairman | Oncopeptides |
| CEO | Opticin Therapeutics |
| Wealth Creation Project Manager | Oxford AHSN |
| CEO | Oxford BioMedica |
| Investment Network Manager | Oxford Investment Opportunity Network |
| Director | Oxford Technology |
| Partner, Corporate Finance | Panmure Gordon & Co. |
| Director, Specialist Healthcare Sales | Panmure Gordon & Co. |
| Director, Healthcare, Equity Research | Panmure Gordon & Co. |
| Director, Healthcare, Equity Research | Panmure Gordon & Co. |
| CEO & Co-founder | Parkure |
| CEO | Peptinnovate |
| Director, CTI | Pfizer |
| Editor | Pharmafocus |
| Producer & Business Development | PharmaTelevision |
| Studio Manager | PharmaTelevision |
| Vice President | PharmaVentures |
| CEO | PharmaVentures |
| Managing Partner | Phase4 Ventures |
| CEO | Phico Therapeutics |
| Chairman & CEO | Pluristem |
| CEO | Poiesis Therapeutics |
| Fund Manager | Polar Capital |
| Fund Manager | Polar Capital |
| Chief Financial Officer | Precision Medicine Catapult |
| Director of Marketing | Precision Medicine Catapult |
| CEO | Precision Medicine Catapult |
| CEO | ProAxsis |
| Director | Prodra Health |
| CEO | PsiOxus Therapeutics |
| CFO | Psioxus Therapeutics |
| Managing Director | Raglan Capital |
| Investment Director | Rainbow Seed Fund |
| Investment Director | Rainbow Seed Fund |
| Vice-President, Global Conferences & Events | RBC Capital Markets |
| Vice-President, Global Investment Banking, Healthcare | RBC Capital Markets |
| Vice-President, Client & Marketing Strategy | RBC Capital Markets |
| Director, Global Investment Banking, Healthcare | RBC Capital Markets |
| Managing Director, Healthcare, EMEA | RBC Capital Markets |
| CEO | Re-Pharm |
| CFO | Redbrae Ventures |
| CFO | Redx Pharma |
| Managing Partner | RMI Partners |
| Head, Academic Relations and Collaborations | Roche |
| Partner | Rosetta Capital |
| Deputy Director | Royal Veterinary College |
| Business Development Manager | Royal Veterinary College |
| CEO | Ryboquin Company |
| Head of Europe, External Science and Partnering Strategy | Sanofi |
| CEO | Sareum |
| Partner | Sarum Partners |
| Managing Partner | Sciad Communications |
| Managing Partner | Sciad Communications |
| Data Editor | SCRIP |
| CEO Strategy and Business Development | SEEK |
| Serial Biotechnology Entrepreneur and Business Angel | Serial Biotechnology Entrepreneur and Business Angel |
| Senior Investment Analyst | Seroba Life Sciences |
| Partner | Seroba Life Sciences |
| Managing Partner | Seroba Life Sciences |
| CEO | Shield Therapeutics |
| Development and Partnering Consultant | Shin Poong Pharma |
| Head of Business Development | Sigma-Tau Rare Disease |
| CEO | Sigma-Tau Rare Disease |
| CEO | Skyepharma |
| Co-Founder | SkyLab Bio |
| Investment Director | SPARK Impact |
| Head of Life Sciences | SPARK Venture Management |
| Commercial Director | Sphere Fluidics |
| Partner | SR-One |
| Partner | SR-One |
| Partner | SR-One |
| Director | Stealthyx |
| CEO | Stevenage Bioscience Catalyst |
| CEO | Sunergos Innovations |
| Company Creation and Growth Executive | Sunergos Innovations |
| Operating Partner | SV Life Sciences |
| CEO | Sygnature Discovery |
| Partner | Syncona Partners |
| Partner | Syncona Partners |
| CEO | Syndicate Room |
| CEO | Synpromics |
| CEO | Taragenyx |
| Managing Director | Tassi & Co. |
| Business Development Manager | The BioHub Birmingham |
| Founder | The Fulford Group |
| News Editor | The Pharma Letter |
| Co-Founder and Partner | The Puguang Investment Holding Group |
| Leisure and Pharmaceutical Reporter | The Sunday Times |
| Senior Business Analyst | The Wellcome Trust |
| Head, Business Development, Innovations | The Wellcome Trust |
| Manager, Ireland | Tonix Pharma Limited |
| Global Regulatory Specialist | Tonix Pharma Limited |
| Investor Relations | Tonix Pharma Limited |
| CEO | Tonix Pharmaceuticals |
| Analyst | Trinity Delta |
| Analyst | Trinity Delta |
| CEO | Trovagene |
| CFO | Trovagene |
| Regenerative Medicine Bioprocessing Unit | University College London |
| Collaboration Manager for Health and Pharma | University of Southampton |
| SETsquared Business Incubation Centre Manager | University of Southampton |
| CEO | Vasgen |
| Partner | Venner Shipley |
| Partner | Ventac Partners |
| Partner | Ventac Partners |
| Partner | Ventac Partners |
| Partner | Ventac Partners |
| CEO | Verona Pharma |
| CEO | Versantis |
| CEO | VHsquared Limited |
| Managing Partner | Visium Asset Management |
| Principal | Visium Asset Management |
| Business Development Manager | Warwick Ventures |
| Solicitor | White & Case |
| Partner | WilmerHale |
| Non Exec Chair | Woodford Patient Capital |
| Partner | Wren Capital |
| CEO | Yaqrit |
